Header Logo

Connection

SHALINI MAKAWITA to Research Design

Back to Details
This is a "connection" page, showing publications SHALINI MAKAWITA has written about Research Design.
SHALINI MAKAWITA
Connection Strength
0.128
Research Design
  1. Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial. Future Oncol. 2020 Oct; 16(30):2375-2384.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.